title: Endophthalmitis caused by Acinetobacter baumanni: a case series.
abstract: OBJECTIVE
  To profile the etiology, clinical outcomes and drug sensitivity patterns in endophthalmitis caused by Acinetobacter baumanni.
  
  
  METHODS
  Retrospective analysis of all the cases of Acinetobacter baumanni endophthalmitis presenting to tertiary referral care ophthalmic hospital in Eastern India from January 2009 to December 2011 were done.
  
  
  RESULTS
  A total of four cases were included in the study. Out of the four cases one was post traumatic and the rest were post cataract surgery. All the cases underwent vitreoretinal surgical intervention followed by intravitreal antibiotics. A. Baumanni was isolated from vitreous in all the cases. Among all the drugs tested bacteria were found sensitive to ciprofloxacin (100 %) whereas all tested resistant to ceftazidime. Out of the four cases one had to be eviscerated, another developed retinal detachment post vitrectomy, one was phthisical at final followup, and only one patient achieved a vision of 20/200 with clear media and attached retina at final visit.
  
  
  CONCLUSIONS
  A. Baumanni is a very rare cause of endophthalmitis with poor visual and anatomical outcomes. Ciprofloxacin should be considered as first the line intravitreal antibiotic.
authors.affiliation: Vitreo Retina Services, Aditya Birla Sankara Nethralaya, Kolkata, West Bengal, India. rayrupak@gmail.com
authors.forename: R
authors.initials: R
authors.lastname: Roy
authors.forename: P
authors.initials: P
authors.lastname: Panigrahi
authors.forename: J
authors.initials: J
authors.lastname: Malathi
authors.forename: S S
authors.initials: SS
authors.lastname: Pal
authors.forename: K
authors.initials: K
authors.lastname: Nandi
authors.forename: A
authors.initials: A
authors.lastname: Patil
authors.forename: E
authors.initials: E
authors.lastname: Nigam
authors.forename: V
authors.initials: V
authors.lastname: Arora
mesh_terms: D000151:Acinetobacter Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000302:isolation & purification*; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002387:Cataract Extraction; D002648:Child; D002939:Ciprofloxacin / Q000627:therapeutic use; D009877:Endophthalmitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D015807:Eye Injuries, Penetrating / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011183:Postoperative Complications; D012189:Retrospective Studies; D014792:Visual Acuity; D014822:Vitreous Body / Q000382:microbiology
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin